At our 25th September EPHMRA Chapter Meeting in Basel, we have Ümit Aktas and Melike Merdan presenting their Paper

At our 25th September EPHMRA Chapter Meeting in Basel, we have Ümit Aktas and Melike Merdan, from Bayer | Pharmaceuticals presenting their paper entitled: ‘Navigating the Path to Adoption: Unlocking Early RXers combining Segmentation and Machine Learning’.

This paper aims to identify early adopters of the product to be launched, a novel treatment for hot flashes and night sweats due to menopause, and analyse their characteristics and motivations using a combination of PMR and data analytics to generate strategic insights in key launch countries. Additionally, it is aimed to explore various drivers influencing the early adoption of the product to be launched among different HCP specialties and how these insights can inform strategic marketing efforts.

Our convenor for this paper is Ana Maria Aguirre-Arteta of Novartis

11 Aug 2025

At our 25th September EPHMRA Chapter Meeting in Basel, we have Ümit Aktas and Melike Merdan presenting their Paper

At our 25th September EPHMRA Chapter Meeting in Basel, we have Ümit Aktas and Melike Merdan, from Bayer | Pharmaceuticals presenting their paper entitled: ‘Navigating the Path to Adoption: Unlocking Early RXers combining Segmentation and Machine Learning’.